Safety assessment and biochemical marker response following intravenous zoledronic acid in children and adolescents with osteogenesis imperfecta and other bone disorders

Authors
Category Primary study
JournalEndocrine Reviews
Year 2015
This article has no abstract
Epistemonikos ID: 2012082f2c3fcb093b8eac3dfa66283a83616b4b
First added on: Feb 08, 2025